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of STEMI. Out of all the deaths, pre-procedural cardiogenic shock, cardiac arrest,
CHF, and sustained ventricular tachycardia, were present in 48%, 31%, 29%, and 7%
patients, respectively. Overall, only 42 (27%) patients died from PCI-related events,
and the majority of these were related to deﬁnite (5%) or presumed (15%) subacute
stent thrombosis. The most common cause of mortality was non-PCI-related cardiac
death (73 patients, 47%), with post-STEMI cardiogenic shock (36%) being the most
common etiology. Forty-four patients (28%) died from non-cardiac-related causes,
and anoxic encephalopathy (16%) after cardiac arrest complicating STEMI was the
most common cause in this category.
Conclusions: The majority of the deaths after PCI in a regional cardiac centre were
related to the patients’ presenting illnesses and comorbidities, rather than PCI-related
causes, which would be a better marker of PCI quality.
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Background: The MGuard Stent (MGS) was designed to prevent distal emboli-
sation of thrombus and has been shown to improve microcirculation in ST-eleva-
tion myocardial infarction (STEMI). However, there are no real world data
comparing it with the bare metal stent (BMS). The aim of this study is to deter-
mine the efﬁcacy and safety of the MGS in STEMI in the real world compared to
the BMS.
Methods: All STEMI patients undergoing primary angioplasty between July 2011
and January 2013 were included in the study except patients with cardiogenic shock
(Killip IV) or those in which the DES was implanted. In total, 262 patients were
included from a single centre, of which 35.9% had an MGS implanted. Two groups of
79 patients were established after propensity score matching (PSM), and they were
similar in terms of baseline and periprocedural variables.
Results: The mean follow-up was 321  12.94 days. There was no difference in
mortality (7.6% in both groups), major adverse cardiac events (MACE) (20.3% vs.
12.7%, P ¼ 0.198), non-cardiac mortality or non-fatal myocardial infarction (6.3%
in both groups). Target lesion revascularisation (TLR) was signiﬁcantly higher in
the MGS group (11.4% (9) vs. 1.3% (1) P < 0.01; RR 10.02 [1.23 to 81.16])
(Table 1).Table 4
Unmatched Matched
MGS
(n ¼ 92)
BMS
(n ¼ 170) P
MGS
(n ¼ 79)
BMS
(n ¼ 79) P
MACE 18.5% (17) 14.1 (24) 0.512 20.3% (16) 12.7% (10) 0.198
All-cause mortality 6.5% (6) 8.8% (15) 0.354 7.6% (6) 7.6% (6) 1
Cardiovascular
mortality and non-
fatal MI
7.6% (7) 7.1 (12) 0.870 6.3% (5) 6.3% (5) 1
Reinfarction 4.3% (4) 2.4% (4) 0.370 5.1% (4) 2.5% (2) 0.405
Heart failure 3.2% (3) 1.7% (3) 0.290 3.8% (3) 1.3% (1) 0.305
TLR 9.8%(9) 2.9% (5) 0.019 11.4% (9) 1.3% (1) 0.009
TVR 9.8%(9) 2.9% (5) 0.019 11.4% (9) 1.3% (1) 0.009
Stent thrombosis 2.2% (2) 0.6% (1) 0.250 2.4% (2) 1.3% (1) 0.560
Acute 1.1% (1) 0.0% (0) 1.3% (1) 0.0% (0)
Subacute 1.1% (1) 0.6% (1) 1.3% (1) 1.3% (1)
Peak troponin I
(ng/dL)
90.16 
82.11
115.53 
128.88
0.444 91.32 
86.08
95.75 
105.20
0.683Conclusions: Our study is the ﬁrst to compare the MGS with the BMS in STEMI in
the real world, and it also appears to conﬁrm that although the MGS is a safe device in
STEMI that is not associated with increased mortality, it is associated with a higher
long-term TLR rate.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/AcTCT-43
Direct Culprit Vessel Primary PCI to LAD Followed by Contra Lateral
Angiography by Transradial Route in Acute Myocardial Infarction - Direct
Study
T. Ghose1, Kuldeep Arora1, S. Yadav1
1Paras Hospitals, Gurgaon, New Delhi, India
Background: Percutaneous coronary intervention (PCI) of the infarct related arter-
y(IRA) during primary PCI for ST elevation myocardial infarction (STEMI) is
appropriate. Two retrospective analyses suggested that, direct PCI to the IRA without
knowledge of the anatomy of the contra lateral artery is feasible .This approach would
shorten the door to balloon time which is a validated surrogate for mortality in AMI.
We have reported the feasibility of such an approach during transradial primary PCI in
a pilot study (Direct prospective study). In the present clinical study we tested the
hypothesis that in anterior STEMI, direct PCI to left anterior descending (LAD) artery
before right coronary artery angiography is feasible and this would shorten the door to
balloon (d2b) time, even in the hands of operators who have shifted from femoral to
radial approach.
Methods: Anterior wall STEMI was diagnosed by standard criteria. All consecutive
patients of anterior MI admitted between March 2012 to April 2014 were studied
prospectively. Patients with cardiogenic shock were excluded. Patients were pre-
treated with chewable aspirin 150 to 325 mg , ticagrelor 180 mg and atorvastatin 80
mg and shifted to cath lab . Radial access was obtained by anterior wall puncture of
the right radial artery. LMCA was hooked with 6F XB guiding catheter and primary
PCI to LAD was done as per standard protocol. After successful PCI to LAD, the
RCA angiogram was performedwith a 5 F TF catheter . All the intervals were
recorded.
Results: 41 patients of anterior MI were treated. 30 drug eluting stents and 12 bio-
resorbable vascular scaffolds were deployed. The median d2b time was 35+11.8
minutes and the mean d2b time was 36.46+ 14.3min. In two cases SL (2) and (8), the
RCA angiogram required multiple attempts with different catheters. Prior RCA
angiogram would have prolonged the median d2b time by 2.45 minutes (p¼0.05 sec)
and mean d2b time by 4.76 minutes (p¼< 0.05 sec).
Conclusions: From this multicenter study, we conclude that in anterior wall
STEMI, it is feasible to perform PCI to LAD directly without knowing the RCA
anatomy which signiﬁcantly shortens the d2b time. Randomized controlled trial is
warranted.TCT-44
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Background: Patients with ST elevation myocardial infarction (STEMI) who are
transferred for primary PCI from a non-PCI facility have longer reperfusion times
which may be associated with poorer clinical outcomes. The aim of this study was to
compare in hospital clinical outcomes among patients presenting directly to a PCI
facility (Non Transfer STEMI group) with those transferred from non-PCI facility for
primary PCI (Transfer STEMI group).
Methods: A retrospective analysis of patients undergoing primary PCI for acute
STEMI from July 2009 to Dec 2013 at a tertiary care PCI hospital was performed.
Patients were identiﬁed as Non Transfer STEMI (n¼501) and Transfer STEMI
(n¼507). Demographic characteristics, risk factors and in hospital clinical outcomes
were compared between the two groups.
Results: The basic demographic proﬁles and cardiovascular risk factors were very
similar between the two groups. The percentage of patients who presented with
cardiogenic shock and/or cardiac arrest in both groups was similar (12.8% vs 14.4%
respectively, p¼0.45). The goal door to balloon time (DTB) was achieved in 85%
of patients in Non-Transfer STEMI (< 90 min) group and 33% of patients in
Transfer STEMI group (< 120 min). 38% of patients in the transfer STEMI group
had DTB time between 120 to 180 minutes. Occurrence of Post PCI cardiogenic
shock, CHF and stroke was similar between the 2 groups. The all cause in hospital
mortality was similar in Non Transfer STEMI vs Transfer STEMI group (5.2% vs
5.3%, p¼0.9)ute Myocardial Infarction B13
